Abatacept for rheumatoid arthritis

A new Cochrane review examines the research into abatacept, one of the newer drugs for rheumatoid arthritis. Chris Mavergames from the German Cochrane Centre spoke with Lara Maxwell, Managing Editor of the Cochrane Musculoskeletal Group, based at the University of Ottawa , in Canada about her findings